Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

38.53
BATS BZX Real-Time Price
As of 1:23pm ET
 -2.72 / -6.59%
Today’s Change
14.16
Today|||52-Week Range
50.49
+23.30%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Y-mAbs Therapeutics, Inc have a median target of 48.00, with a high estimate of 52.00 and a low estimate of 35.00. The median estimate represents a +24.58% increase from the last price of 38.53.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Y-mAbs Therapeutics, Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.78
Sales
$0.00
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.10%
 
 
 
 
 
 
Growthannually -37.20%
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.